IGFALS | Insulin-like growth factor binding protein, acid labile subunit | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
NXPE1 | Neurexophilin and PC-esterase domain family, member 1 | Predicted membrane proteins
| | | | | Group enriched |
PLA2G12B | Phospholipase A2, group XIIB | Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
REP15 | RAB15 effector protein | | | | | | Group enriched |
RP11-77K12.7 | | | | | | | Group enriched |
SOAT2 | Sterol O-acyltransferase 2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
TMEM82 | Transmembrane protein 82 | Predicted membrane proteins
| | | | | Group enriched |
APOBEC1 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 | | | | | | Group enriched |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CHST5 | Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CTSE | Cathepsin E | Enzymes Predicted secreted proteins
| | | | | Group enriched |
DHRS11 | Dehydrogenase/reductase (SDR family) member 11 | | | | | | Group enriched |
FABP2 | Fatty acid binding protein 2, intestinal | Cancer-related genes Plasma proteins
| | | | | Group enriched |
KDM8 | Lysine (K)-specific demethylase 8 | Enzymes
| | | | | Group enriched |
NXPE4 | Neurexophilin and PC-esterase domain family, member 4 | Predicted secreted proteins
| | | | | Group enriched |
PRAP1 | Proline-rich acidic protein 1 | Predicted secreted proteins
| | | | | Group enriched |
SLC5A1 | Solute carrier family 5 (sodium/glucose cotransporter), member 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
TMEM236 | Transmembrane protein 236 | Predicted membrane proteins
| | | | | Group enriched |
UGT1A10 | UDP glucuronosyltransferase 1 family, polypeptide A10 | Cancer-related genes Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
VIL1 | Villin 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Group enriched |
AOC1 | Amine oxidase, copper containing 1 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
BEST2 | Bestrophin 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
C10orf99 | Chromosome 10 open reading frame 99 | Predicted secreted proteins
| | | | | Group enriched |
CDX1 | Caudal type homeobox 1 | Transcription factors
| | | | | Group enriched |
DMBT1 | Deleted in malignant brain tumors 1 | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
GCKR | Glucokinase (hexokinase 4) regulator | | | | | | Group enriched |
HHLA2 | HERV-H LTR-associating 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
HOXA13 | Homeobox A13 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
HOXD11 | Homeobox D11 | Cancer-related genes Transcription factors
| | | | | Group enriched |
LYPD8 | LY6/PLAUR domain containing 8 | | | | | | Group enriched |
NR1I2 | Nuclear receptor subfamily 1, group I, member 2 | FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Group enriched |
PSAPL1 | Prosaposin-like 1 (gene/pseudogene) | Predicted secreted proteins
| | | | | Group enriched |
TPH1 | Tryptophan hydroxylase 1 | Enzymes FDA approved drug targets
| | | | | Group enriched |
TPSG1 | Tryptase gamma 1 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
TRPV6 | Transient receptor potential cation channel, subfamily V, member 6 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
AMTN | Amelotin | Predicted secreted proteins
| | | | | Group enriched |
AQP10 | Aquaporin 10 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CDH17 | Cadherin 17, LI cadherin (liver-intestine) | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CLRN3 | Clarin 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
FOXA3 | Forkhead box A3 | Transcription factors
| | | | | Group enriched |
FUT9 | Fucosyltransferase 9 (alpha (1,3) fucosyltransferase) | Predicted membrane proteins
| | | | | Group enriched |
GOLT1A | Golgi transport 1A | Predicted membrane proteins
| | | | | Group enriched |
GPA33 | Glycoprotein A33 (transmembrane) | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
IGSF23 | Immunoglobulin superfamily, member 23 | Predicted membrane proteins
| | | | | Group enriched |
MYO1A | Myosin IA | Disease related genes Plasma proteins
| | | | | Group enriched |
NEUROD1 | Neuronal differentiation 1 | Disease related genes Transcription factors
| | | | | Group enriched |
NTS | Neurotensin | Predicted secreted proteins
| | | | | Group enriched |
SLC6A4 | Solute carrier family 6 (neurotransmitter transporter), member 4 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SULT1E1 | Sulfotransferase family 1E, estrogen-preferring, member 1 | Cancer-related genes Enzymes
| | | | | Group enriched |
AC106876.2 | Uncharacterized protein | | | | | | Group enriched |